Table of contents
A spinal cord stimulator is a surgically implanted medical device designed to alleviate chronic pain, particularly in the back and spine. These devices are marketed as a pain management solution that works by disrupting nerve signals before they reach the brain. However, a growing number of patients are experiencing not only a failure to relieve pain but also new and sometimes permanent complications. These complications can include electrical shocks, burning pain, infections, lead migration, device malfunction, and the need for additional surgeries to reposition or remove the device, which was initially intended to improve their quality of life.
This page provides information about spinal cord stimulator lawsuits and the reasons behind their increasing prevalence nationwide. It examines the allegations made by patients, the documented failures of these devices, and why many of these cases extend beyond typical medical malpractice claims. The most serious lawsuits focus not merely on surgical errors but on the design, testing, and approval processes of modern spinal cord stimulators, as well as whether patients were adequately informed about the risks now frequently reported in medical records and by the FDA.
Many individuals seek information about potential spinal cord stimulator settlement amounts and how compensation is determined when a device causes lasting harm. This determination is complex and depends on the complete medical history, including the costs of repeat surgeries, explantation, permanent functional loss, and the subsequent consequences when a pain management device leaves a patient in a worse condition than before implantation.
The following sections provide a detailed analysis of the allegations, the regulatory background of these devices, the types of injuries reported, and the methods used to assess compensation in significant spinal cord stimulator cases.
If you or someone you know has experienced complications following spinal cord stimulator implantation, this information is intended to help you understand if you may have a claim and why these cases are being given serious consideration across the country. Contact Nguyen Injury Lawyer for a free, no-obligation consultation at XXX-XXX-XXXX.
Spinal Cord Stimulator Lawsuit Updates
March 22, 2026 – Abbott Proclaim XR5 Lawsuit Alleges Reprogramming by Sales Reps, Repeat Lead Migration, and Explant
A recent spinal cord stimulator lawsuit filed in the Northern District of Illinois targets Abbott and its Proclaim XR5 system, alleging issues that go beyond typical device failures. The plaintiff claims that Abbott sales representatives assured her before implantation that the permanent Proclaim XR5 would provide long-term pain relief, was clinically validated, and would perform as well as or better than the temporary trial stimulator. The lawsuit asserts that these promises proved false, as the permanent implant allegedly failed to provide lasting relief and instead led to increased pain and repeated complications.
The complaint also emphasizes Abbott’s actions after the implantation. The plaintiff alleges that Abbott representatives repeatedly programmed and reprogrammed the device post-surgery, sometimes without proper physician oversight, and later instructed her by phone on how to adjust the device herself. These representatives were presented as the only ones capable of properly managing the system, which allegedly prevented the plaintiff from recognizing sooner that the device was failing. This is a critical point because it shifts the case beyond a standard product defect claim to allegations that company representatives directly influenced treatment decisions after implantation—a practice that raises serious concerns.
Lead migration is another significant issue highlighted in the lawsuit. The plaintiff claims that one lead migrated in July 2023, necessitating revision surgery the following month. However, the problems persisted. After the revision, the plaintiff experienced a recurrence of pain and questioned whether the leads had migrated again. She alleges that Abbott representatives dismissed this possibility and instead increased the stimulation settings. A doctor subsequently discovered a second lead migration in September 2023. By March 2024, the plaintiff asserts that the Proclaim XR5 had to be surgically removed due to its complete loss of therapeutic effectiveness.
This complaint reflects a broader regulatory argument common in these claims. The Proclaim XR5 was marketed under a PMA lineage that originated with a much older device approved in 2001, even though Abbott and its predecessors allegedly made over 230 supplemental changes involving firmware, waveform architecture, battery design, wireless programming, and other essential functions without submitting a new PMA. The complaint also references Class I recalls involving Abbott Proclaim devices and argues that the current system was significantly different from the originally approved one, while patients and doctors were not adequately warned about the evolving risks.
February 27, 2026 – Spinal Cord Stimulator Lawsuit Dismissed
A federal judge in Michigan dismissed a WaveWriter spinal cord stimulator case against Boston Scientific, ruling that the claims were preempted under the FDCA and the Medical Device Amendments because the device underwent FDA Premarket Approval.
The plaintiff alleged that the implant ceased functioning as intended, caused painful, shocking sensations after revisions, could not be successfully reprogrammed, and ultimately required removal, resulting in lasting nerve symptoms. The lawsuit was based on failure to warn and manufacturing defect theories, arguing that the company should have responded to post-market safety signals and that the device was not manufactured in compliance with federally approved specifications.
The court determined that the warning theory would necessitate warnings beyond those approved by the FDA and that the manufacturing and negligence theories were not linked to a specific parallel Michigan duty. Consequently, the case was dismissed with prejudice.
Preemption is a legal defense asserting that federal device regulations supersede state tort claims for PMA Class III devices unless a plaintiff can demonstrate a traditional state law claim that mirrors a concrete federal requirement. This approach often requires detailed quality system information at the pleading stage, which plaintiffs typically cannot access without discovery, effectively turning the manufacturer’s control of information into a protective measure.
If higher courts widely adopt this reasoning, it could narrow spinal stimulator cases to a small subset of precisely pleaded manufacturing deviation claims and weaken leverage across the litigation. Nguyen Injury Lawyer believes that preemption should not serve as a blanket bar, as PMA approval does not grant lifetime immunity, and companies must still adhere to regulations and respond to post-market information.
February 19, 2026 – Spinal Cord Stimulator MDL Sought
A group of plaintiffs has requested the U.S. Judicial Panel on Multidistrict Litigation to consolidate all federal lawsuits involving Abbott and Boston Scientific spinal cord stimulators into an MDL in the Northern District of Illinois.
The motion, filed under 28 U.S.C. § 1407, seeks to centralize at least fifteen pending cases across five jurisdictions, with many also naming the FDA under the Administrative Procedure Act.
Plaintiffs argue that the cases share fundamental factual and legal questions concerning device design, federal regulatory compliance, and preemption defenses. Consolidation would prevent inconsistent rulings and duplicative discovery. No court has yet ruled on key motions, including federal preemption defenses that are already fully briefed in at least one case.
The lawsuits allege that Abbott’s spinal cord stimulator line traces back to the Genesis system approved in 2001 under PMA P010032, and Boston Scientific’s line to the Precision system approved in 2004 under PMA P030017. Plaintiffs contend that neither original approval was supported by independent clinical trial data specific to the devices. Instead, the FDA allegedly relied on published literature involving other manufacturers’ systems.
Since then, both companies have introduced successive generations of stimulators through PMA supplements rather than new PMA applications, despite incorporating substantial changes such as multiwaveform stimulation modes, posture-adaptive programming, expanded electrode arrays, Bluetooth-enabled interfaces, revised battery architecture, and redesigned leads. Plaintiffs argue these modifications fundamentally altered the devices’ safety profiles while avoiding the more rigorous scrutiny required for new Class III approvals.
The FDA received an astonishing 107,728 adverse event reports related to spinal cord stimulators over a four-year period, including more than 30,000 complaints of unsatisfactory pain relief. Plaintiffs allege that the agency failed to meaningfully review supplemental approvals and unlawfully permitted manufacturers to bring materially different devices to market through a regulatory shortcut.
Every spinal cord stimulator lawsuit asserts injuries, including lead migration, electrical shocks, burning sensations, neurological injury, autonomic dysfunction, and chronic pain exacerbation. With roughly 50,000 spinal cord stimulators implanted annually and the two companies controlling a majority market share, plaintiffs argue that tens of thousands of additional claims may exist. They contend that consolidating the cases in Illinois, where Abbott is headquartered and multiple actions are already pending, would promote judicial economy and ensure consistent rulings on preemption and regulatory oversight issues.
February 2, 2026 – New Spinal Cord Stimulator Lawsuit
A new spinal cord stimulator lawsuit has been filed alleging that a Boston Scientific spinal cord stimulator battery malfunctioned and required surgical removal after the device failed, causing worsening pain and complications. This adds to the growing litigation over implanted neuromodulation devices that plaintiffs claim did not perform as represented and led to additional procedures.
October 17, 2026 – Spinal Cord Lawsuit in California
A federal lawsuit was filed in the Central District of California against Boston Scientific and the FDA over the Spectra WaveWriter device. The complaint alleges that lead migration and subsequent complications, including cardiac arrhythmia, resulted from substantial device modifications that improperly used the FDA’s PMA supplement pathway instead of requiring a full PMA review. The plaintiff is seeking damages and a jury trial.
Spinal Cord Stimulators
Spinal cord stimulation devices are Class III implantable neuromodulation systems designed to deliver controlled electrical impulses to the spinal cord to manage chronic, intractable pain. These systems typically include an implantable pulse generator, one or more electrical leads placed near the spinal cord, and an external controller that allows the patient to adjust stimulation levels.
The principle behind spinal cord stimulation is that targeted electrical impulses applied to the dorsal columns of the spinal cord can interfere with or alter the transmission of pain signals before they reach the brain. By modulating these signals, the devices aim to provide relief for patients whose pain has not responded to more conventional treatment options.
Despite their intended benefits, spinal cord stimulation systems carry significant and well-documented risks. Reported complications include device migration, lead fracture or displacement, battery malfunction, infection, neurological injury related to stimulation, worsening pain, and autonomic dysfunction. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for more information.
Spinal Cord Stimulator Classification and Lawsuits
Due to the significant potential risks, the FDA classifies spinal cord stimulation systems as Class III medical devices. This classification mandates stringent Premarket Approval and additional review for any design or functional changes that could impact the device’s safety or effectiveness.
Spinal Cord Stimulator Lawsuits: Allegations of Defective Medical Devices
Across the country, patients are filing lawsuits concerning spinal cord stimulators (SCS), claiming that these implantable pain management devices were defectively designed and are unreasonably dangerous. According to adverse event data from the FDA, thousands of complaints have been filed regarding spinal cord stimulators. These include reports of burns, infections, device migration, electrical malfunctions, and the necessity for repeated corrective surgeries.
Major manufacturers, including Boston Scientific, Medtronic, Abbott, and Nevro Corp, are accused of neglecting to adequately warn patients and physicians about the known risks linked to these devices. Independent scientific research has raised concerns that spinal cord stimulators are susceptible to lead migration, hardware failures, and electrical defects, potentially leading to severe neurological injuries and long-term complications.
Many patients report that they were not fully informed about these risks before the implantation procedure. After enduring burns, infections, increased pain, paralysis, or undergoing revision surgeries or complete device removal, patients often experience considerable physical pain, emotional distress, and financial strain. Consequently, injured individuals and their families are pursuing spinal cord stimulator lawsuits to seek compensation and accountability. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX for a consultation.
Spinal cord stimulator lawsuits differ from typical medical malpractice cases not only in the severity of the injuries but also in the regulatory and design history of these devices. Many of the most serious claims being filed today do not solely focus on surgical errors or isolated malfunctions. Instead, they examine the approval process for modern spinal cord stimulators, how drastically they have changed over time, and whether patients were adequately protected by the safety testing they were led to believe occurred.
Reported Spinal Cord Stimulator Complications
Injuries alleged in spinal cord stimulator lawsuits include:
Common Alleged Injuries and Complications
- Lead migration requiring revision surgery
- Electrical malfunction causing shocks or burns
- Device overheating
- Hardware failure
- Infection
- Scar tissue complications
- Worsening neuropathic pain
- Paralysis or weakness
- Autonomic dysfunction
- Bowel or bladder loss
- Cardiac complications
- Death following postoperative complications
One reported case involved an elderly patient who developed Ogilvie syndrome after implantation, as we discuss below. This complication progressed to bowel rupture and multi-organ failure. While the cause remains disputed, similar autonomic complications have been reported following neuromodulation procedures.
Another lawsuit alleges that a WaveWriter Alpha stimulator migrated and delivered painful shocks, with company representatives allegedly adjusting the device without a physician present.
These scenarios are not identical, but they share common themes: device movement, electrical malfunction, worsening symptoms, and inadequate warnings. If you’ve experienced similar issues, contact Nguyen Injury Lawyer through our website at https://www.nguyeninjurylawyer.com to discuss your legal options.
How FDA Approval Is Being Used As A Shield
One of the first arguments spinal cord stimulator manufacturers make when patients are injured is that the device has FDA approval. The implication is that if the device was approved, it must be safe. However, this overlooks how spinal cord stimulators entered the market and how they have evolved since then.
Spinal cord stimulators are classified as Class III medical devices, the highest risk category under federal law. In theory, this classification means the device must undergo rigorous premarket approval, including clinical testing, before it can be sold. In practice, many of today’s spinal cord stimulators trace their approval back to much older devices, approved decades ago, through a regulatory pathway that allows manufacturers to make changes without submitting new clinical evidence each time.
Manufacturers are allowed to update devices through PMA supplements. These supplements are intended for limited, incremental changes that do not significantly alter how a device works or its risk level. The problem arises when companies use this process to implement extensive design changes over many years without seeking a full review from the FDA.
In the spinal cord stimulator sector, manufacturers have made major modifications to battery systems, lead designs, stimulation waveforms, wireless communication features, posture-adaptive algorithms, and multi-source current delivery. These are not minor adjustments. They directly affect how electrical signals are delivered to the spinal cord and how the device behaves inside the body.
However, many of these changes were approved through paperwork rather than new human trials. As a result, patients may receive devices that are significantly different from the versions originally approved, even though the FDA approval label remains the same. From the patient’s perspective, the device appears fully vetted. From a regulatory standpoint, the safety data often lags behind the technology. Nguyen Injury Lawyer is here to help if you’ve been injured by a spinal cord stimulator; call us at XXX-XXX-XXXX.
This regulatory gap has real-world implications. When a device malfunctions, migrates, overheats, or delivers unintended electrical shocks, manufacturers often argue that these outcomes fall within “known risks.” However, a risk cannot be truly known if the device has evolved beyond the version that was properly studied.
Lawsuits now being filed across the country allege that manufacturers exploited this regulatory structure by making incremental changes without conducting the necessary testing to reveal long-term failure rates or rare but devastating complications. Plaintiffs also claim that warnings never reflected how these newer systems behaved once implanted in patients.
The result is a familiar pattern in modern medical device litigation. FDA approval becomes a talking point, not a safeguard. Devices reach patients faster than the science can keep up, and serious complications are only fully recognized after thousands of people have already been exposed.
This is why many spinal cord stimulator lawsuits focus not just on individual injuries but also on whether manufacturers complied with the spirit and intent of the regulatory system. The core allegation is not that innovation is bad, but that innovation without accountability shifts the risk onto patients who never agreed to be test subjects. Contact Nguyen Injury Lawyer through our contact page: https://www.nguyeninjurylawyer.com/contact.
Elderly Patient Dies After Colon Complication Following SCS Implant
In mid-December, an elderly man received a spinal cord stimulator to treat chronic pain. Shortly after implantation, he developed Ogilvie’s syndrome, a complication that can occur in elderly or medically fragile patients after surgery or neurological interference. It has been reported in connection with spinal procedures and neuromodulation, including SCS implantation, particularly when autonomic nerve function is affected.
The swelling in this patient became so severe that it ruptured his cecum, triggered multiple organ failure, and ultimately led to his death. The condition is believed to be linked to complications from the spinal cord stimulator. Similar reports involving electrocution, infections, and device migration have prompted patients and families nationwide to pursue legal claims against device manufacturers.
Virginia Woman Sues FDA and Boston Scientific Over Defective Device
A Virginia woman has filed a spinal cord stimulator lawsuit against Boston Scientific and the U.S. Food and Drug Administration, alleging that a defective spinal cord stimulator caused severe and worsening injuries after implantation.
According to the complaint, the woman received a WaveWriter Alpha spinal cord stimulator to manage chronic pain, but instead, it worsened her condition, and she experienced electrical shocks, device migration, and escalating physical harm.
The lawsuit further alleges that the device moved from its intended position and delivered painful electrical impulses that were not only ineffective but also dangerous. This movement, referred to as migration, can cause significant damage to the patient.
The patient also claims that company representatives adjusted and altered the device without her physician present, dismissing her concerns even as her condition deteriorated. These allegations mirror reports documented in FDA adverse event data, where other patients have described similar injuries linked to the same device system.
In addition to claims against the manufacturer, the lawsuit raises serious questions about regulatory oversight. The plaintiff alleges that Boston Scientific continued to market and sell a spinal cord stimulator that materially differed from the version originally approved by the FDA, without undergoing proper supplemental review or safety testing. The complaint asserts that these changes increased the risk of injury while depriving patients and physicians of critical information needed to make informed decisions.
The case highlights a growing concern in spinal cord stimulator litigation: that device manufacturers may prioritize speed to market and continued sales over patient safety, while regulators fail to intervene despite mounting evidence of harm. Although the case remains pending, it reflects broader allegations being raised nationwide by patients who say they were never adequately warned about the risks associated with these devices and who now face lasting pain, repeated procedures, and a diminished quality of life. If this sounds like your situation, contact Nguyen Injury Lawyer at XXX-XXX-XXXX.
When Device Reps Cross the Line Into Treatment
One of the more serious issues emerging in spinal cord stimulator litigation is that some lawsuits are not just about the device itself. They focus on the role manufacturer representatives play before and after implantation. The claim is that these representatives are not merely providing technical support. In some cases, they are accused of helping sell the implant by making assurances about long-term pain relief, clinical validation, and expected performance, then remaining heavily involved once problems begin.
A spinal cord stimulator lawsuit may no longer be just about whether the hardware malfunctioned. It might also be about whether patients were influenced by sales-driven promises and then steered through repeated reprogramming efforts instead of getting a candid assessment that the device was failing from their unbiased healthcare providers. Nguyen Injury Lawyer can help you understand your rights; reach out at XXX-XXX-XXXX.
The attorneys at Nguyen Injury Lawyer allege that manufacturer representatives have taken an active role in programming and reprogramming spinal cord stimulators after implantation, sometimes across multiple visits and sometimes with only limited physician involvement. This kind of involvement can blur the line between product support and treatment, especially when the representative is the person the patient is told to rely on when pain worsens, stimulation becomes erratic, or the device stops delivering relief.
These allegations become even more troubling when paired with claims of lead migration, electrical shocks, or sudden loss of therapeutic benefit. One of the recurring themes in spinal stimulator lawsuits is that repeated device adjustments may be used as a temporary response to serious complications, even when the underlying issue may be hardware movement, system instability, or loss of efficacy that reprogramming cannot fix. This looks less like troubleshooting and more like delay.
For further information or to discuss your legal options, please visit https://www.nguyeninjurylawyer.com.
The Importance of Manufacturer Conduct After Implantation
Demonstrating a manufacturer’s ongoing involvement after a device is implanted can significantly strengthen various legal claims. This evidence can bolster allegations of negligent misrepresentation, breach of warranty, failure to warn, and general negligence related to post-implantation actions. It also provides jurors with a more compelling narrative, illustrating that the manufacturer might have been actively engaged while the patient’s condition deteriorated, rather than simply hearing about a device failure.
Abbott’s Recall History and Alleged Warning Failures
A critical aspect of spinal cord stimulator litigation revolves around whether patients and physicians received adequate warnings regarding the real-world performance of newer Abbott systems. The lawsuits against Abbott allege not only that these devices are prone to failure but also that significant risks were downplayed, poorly communicated, or obscured by overly optimistic assurances about safety and efficacy.
Complications associated with spinal cord stimulators extend beyond merely disappointing results. Patients have reported experiencing painful electrical shocks, sudden loss of therapy, charging malfunctions, communication issues between device components, lead migration, and increased pain following implantation. These are not minor side effects for a device designed to alleviate chronic pain; they directly challenge the product’s overall safety and functionality.
Abbott’s history of recalls involving serious device malfunctions also raises concerns. FDA Class I recalls, the agency’s most critical recall category, have been issued for Proclaim-related issues, including unintended painful stimulation, device shutdowns, and therapy delivery failures. Plaintiffs contend that this recall history undermines any claims that the reported problems are isolated or speculative incidents.
The central allegation is that warnings failed to keep pace with technological advancements. As spinal cord stimulator systems evolved through supplemental changes to firmware, battery design, wireless programming, and stimulation features, the associated risks also evolved. However, lawsuits argue that patients were not adequately informed that the implanted device might differ significantly from the originally approved version from years prior.
This gap in warning information is a significant issue in these cases. A manufacturer cannot rely on the argument that a risk was technically known if the actual device changed over time, and the real-world complications became more severe, frequent, or different from what patients and doctors were led to expect. This is why failure-to-warn claims remain central to this litigation, even with ongoing preemption challenges. If you have questions about this, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or through our website at https://www.nguyeninjurylawyer.com.
The Discrepancy Between Trial Stimulators and Permanent Implants
One of the most concerning patterns observed in spinal cord stimulator cases, and one that juries readily understand, involves the disparity between the trial stimulator and the permanent implant.
Patients undergo a trial period where the stimulator works effectively, providing significant pain relief. Doctors confirm positive results, and all parties agree to proceed with the permanent implant.
However, after the permanent device is implanted, the relief gradually diminishes over weeks or months. The pain returns, the hardware shifts, and the system malfunctions, leaving the patient with a non-functional device inside their body.
The fundamental issue is that the trial is not designed to predict long-term performance; its primary goal is to secure the patient’s consent for permanent implantation. Device manufacturers understand that the trial period is the crucial decision-making point. A successful trial leads to permanent implantation, while a failed trial results in the patient declining the procedure. Consequently, the trial is engineered for success through short duration, controlled conditions, and maximized placebo effect. However, it fails to provide an accurate assessment of the permanent implant’s long-term effectiveness, such as six months or two years post-implantation.
Current lawsuits challenge this practice, alleging that the permanent device does not replicate the results of the trial due to the implanted system’s altered behavior over time, lead migration, hardware failure, or the inadequacy of the short-term trial window as a reliable preview of permanent implantation.
This discrepancy is critical because it reframes the entire case. The issue is not always the lack of initial benefit but rather the false confidence created by the trial in a treatment that the permanent device cannot sustain. Patients who follow the process and trust the system may end up with an invasive implant and no long-term relief.
Our attorneys at Nguyen Injury Lawyer believe this argument will resonate with juries. A patient who consents to surgery after a promising trial does not perceive themselves as someone who took a gamble and lost. Instead, they feel misled by a system that initially demonstrated success but ultimately failed to deliver on its promises. This is not an assumption of risk but a breach of trust.
Potential Settlement Amounts in Spinal Cord Stimulator Cases
Individuals inquiring about spinal cord stimulator settlement amounts are typically seeking assurance that their suffering is acknowledged and that the legal system recognizes the extent of the harm they have endured. Spinal cord stimulator lawsuits aim to compensate for the extensive losses that often result from device failures.
For many patients, the initial injury is not the most severe. Subsequent months or years may involve repeated surgeries, hospitalizations, imaging studies, and unsuccessful attempts to repair the malfunctioning device. Each revision surgery carries its own risks, costs, and recovery time. In some cases, the device never functions as intended, while in others, it must be completely removed, resulting in permanent damage and no pain relief.
There is also a significant but less visible cost: the loss of trust in the medical system. Patients often report feeling dismissed when they report shocks, burning sensations, or worsening pain. They are told that these symptoms are rare, expected, or unrelated, even as their quality of life deteriorates. This erosion of trust, combined with physical suffering and financial burden, is a primary factor driving these lawsuits.
Settlement compensation and payouts are considered only after these realities are fully understood. Higher settlement amounts in spinal stimulator cases are typically associated with cases involving clear, documented harm rather than temporary discomfort. The strongest cases often involve multiple revision surgeries, complete device explantation, or injuries that permanently affect neurological function. Contact Nguyen Injury Lawyer today for a free consultation by calling XXX-XXX-XXXX. You can also reach us through our website at https://www.nguyeninjurylawyer.com or by visiting our contact page at https://www.nguyeninjurylawyer.com/contact.
Illustrative Settlement Payout Scenarios
Predicting exact settlement amounts at this stage is speculative. However, the following framework illustrates how compensation and payouts may vary based on the severity of the injury:
- One Revision Surgery, No Explant: Documented shocks or worsening pain with limited permanency.
- Illustrative range: $90,000 to $250,000
- Explantation Required: Removal surgery plus ongoing pain and functional limitations.
- Illustrative range: $150,000 to $550,000
- Multiple Surgeries, Hardware Migration: Two or more revisions, documented migration, or lead failure.
- Illustrative range: $250,000 to $1,100,000
- Neurologic Injury: Documented nerve damage, weakness, gait changes, and long-term deficit.
- Illustrative range: $1,100,000 to $1,900,000
- Bowel Or Autonomic Dysfunction: Loss of bladder or bowel control, autonomic complications, and permanency.
- Illustrative range: $1,900,000 to $2,500,000
Factors Influencing Spinal Stimulator Compensation Payouts
- Number of surgeries, including revision and explantation
- Objective proof of migration, lead failure, overheating, or malfunction
- Neurologic injury or bowel or autonomic dysfunction
- Medical expenses, wage loss, and diminished earning capacity
- Permanency, credibility, and the jurisdiction where the case is filed
The Possibility of Quick Settlements
While a quick settlement is not guaranteed, it can occur. For instance, a lawsuit filed in October alleged that a woman suffered severe and worsening injuries after receiving a spinal cord stimulator manufactured by Boston Scientific. The complaint claimed that the device migrated, delivered painful electrical shocks, and failed to perform as promised. The lawsuit accused the company of selling a defective medical device and failing to warn patients and doctors about known risks, while also raising broader concerns about regulatory oversight.
The plaintiff asserted that the stimulator differed significantly from the version originally approved by the FDA and that these changes increased the risk of harm without adequate testing or disclosure. This case aligns with a growing trend in spinal cord stimulator litigation, focusing less on surgical error and more on device design, post-approval modifications, and inadequate warnings.
In this particular instance, the lawsuit was resolved quickly, with Boston Scientific reaching a settlement in December, less than 60 days after the suit was filed and before any significant pretrial discovery. The timing of the settlement is noteworthy because it occurred early in the litigation process, leaving questions about how these cases will be defended and whether many can be settled without even filing a lawsuit.
Filing a Spinal Cord Stimulator Lawsuit
If you or a loved one has experienced complications after spinal cord stimulator implantation, such as electrocution, burns, infections, neurological injury, or repeated surgeries, you may have legal options. Lawsuits seek compensation for medical costs, lost income, pain and suffering, and long-term disability, while holding manufacturers accountable for unsafe products and inadequate warnings. If you are considering filing a lawsuit, contact Nguyen Injury Lawyer at XXX-XXX-XXXX for a free consultation.
Eligibility Criteria for Spinal Cord Stimulator Lawsuits
Patients who received a spinal cord stimulator expecting relief but instead experienced serious complications may have grounds to pursue a legal claim. The cases that attorneys at Nguyen Injury Lawyer are seeking involve more than just an unfavorable outcome or an unfortunate side effect. They raise broader questions about the design, testing, marketing, and regulation of these devices.
You may qualify if you or a loved one had a spinal cord stimulator implanted and later suffered injuries such as infection, shocks, burns, device migration, neurological damage, or bowel or autonomic complications. The strongest cases for settlement typically involve victims who require repeated revision surgeries or complete device removal. Often, patients report that they were never adequately warned about the potential for these risks.
Eligibility does not depend on whether the device is still implanted, whether symptoms appeared immediately, or whether the manufacturer labeled the complication as “rare.” The key factor is whether the device failed to perform as promised or introduced dangers that were not adequately disclosed. Lawsuits often focus on whether manufacturers minimized known risks, overstated benefits, or continued selling devices that had changed significantly without proper safety review. For more information, contact Nguyen Injury Lawyer through our website at https://www.nguyeninjurylawyer.com.
Legal Options for Families Affected by Spinal Cord Stimulator Complications
In instances where a spinal cord stimulator leads to severe disability or death, families may also have grounds for legal action. This is especially true when complications arise quickly, limiting the possibility of effective medical intervention. These lawsuits address not only the harm suffered by individuals but also the need for accountability in a healthcare system that sometimes prioritizes efficiency and profit over ensuring patient safety in the long run.
If you feel that your concerns regarding a spinal cord stimulator injury were ignored, downplayed, or considered an unavoidable risk, please know that you are not isolated in this experience. Many of the lawsuits currently being pursued across the country began similarly, with patients discovering too late that they were not given complete and accurate information about the device and its potential risks.
Speak with Nguyen Injury Lawyer About Spinal Cord Stimulator Claims
Nguyen Injury Lawyer is actively investigating spinal cord stimulator lawsuits on a national scale. If you or a loved one has experienced physical or psychological harm as a result of a spinal cord stimulator, we encourage you to contact us for a free and confidential case evaluation. You can reach us at XXX-XXX-XXXX or through our online contact form at https://www.nguyeninjurylawyer.com/contact. Let Nguyen Injury Lawyer help you understand your legal rights and explore your options for seeking justice.